Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease

Several ethical aspects in the management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) are still controversial, including family planning and testing for disease presence in at-risk individuals. We performed an online survey aiming to assess the opinion and current clinical practice of Eu...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2017-09, Vol.12 (9), p.e0185779-e0185779
Main Authors: De Rechter, Stéphanie, Kringen, Jonathan, Janssens, Peter, Liebau, Max Christoph, Devriendt, Koenraad, Levtchenko, Elena, Bergmann, Carsten, Jouret, François, Bammens, Bert, Borry, Pascal, Schaefer, Franz, Mekahli, Djalila
Format: Article
Language:English
Subjects:
Accuracy
Adult
Adults
Attitude of Health Personnel
Attitudes
Beliefs, opinions and attitudes
Biology and Life Sciences
Clinical medicine
Cysts
Diagnosis
Disease control
Ethics
Families & family life
Family planning
Family Planning Services
Female
Genetic screening
Genetics
Health risks
Hemodialysis
Hospitals
Human health sciences
Humans
Hypertension
Implantation
Kidney diseases
Kidney transplantation
Legal medicine
Male
Medical diagnosis
Medicine
Medicine and Health Sciences
Middle Aged
Nephrology
NMR
Nuclear magnetic resonance
Offspring
Pediatrics
People and Places
Physicians
Polycystic kidney
Polycystic kidney disease
Polycystic Kidney, Autosomal Dominant - diagnosis
Polycystic Kidney, Autosomal Dominant - physiopathology
Polycystic Kidney, Autosomal Dominant - therapy
Practice
Pregnancy
Risk
Sciences de la santé humaine
Statistical analysis
Surveys and Questionnaires
Transplants & implants
Ultrasonic imaging
Urologie & néphrologie
Urology & nephrology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Several ethical aspects in the management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) are still controversial, including family planning and testing for disease presence in at-risk individuals. We performed an online survey aiming to assess the opinion and current clinical practice of European pediatric and adult nephrologists, as well as geneticists. A total of 410 clinicians (53% male, mean (SD) age of 48 (10) years) responded, including 216 pediatric nephrologists, 151 adult nephrologists, and 43 clinical geneticists. While the 3 groups agreed to encourage clinical testing in asymptomatic ADPKD minors and adults, only geneticists would recommend genetic testing in asymptomatic at-risk adults (P
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0185779